-
England coach McCullum survives review into Ashes drubbing
-
Mixed results for Lyme disease vaccine hit Valneva shares
-
Far-right French president no certainty despite rise of extremes
-
Trump tells AFP 'things are going very well' on Iran
-
Ukraine hits major Russian oil port near Finland
-
EU chief in Australia as trade talks enter 'last mile'
-
UK police probe attack on Jewish ambulances
-
Oil prices slide, European stocks rebound on Trump's Iran remarks
-
Trump announces 'very good' talks with Iran on ending war
-
Arsenal's White gets first England call-up since 2022
-
Greece train tragedy trial adjourned amid courtroom chaos
-
Tottenham face key call as relegation threat grows
-
German court rejects landmark climate case against BMW, Mercedes
-
Trump lifts Iran threat after 'very good' talks on ending war
-
Iran defies Trump Hormuz ultimatum with naval mine threat
-
African players in Europe: Awoniyi seals key win for lowly Forest
-
France ex-PM Lionel Jospin dies aged 88
-
Runway collision kills two pilots, shutters New York airport
-
Hodgkinson in 'shape of her life' with eye on Kratochvilova's record
-
Griezmann given go-ahead to talk with Orlando City
-
Mideast war threatens energy crisis worse than 1970s oil shocks
-
Pilot, co-pilot killed in runway collision at New York airport
-
Plane, fire truck collide on runway at New York's LaGuardia Airport
-
Russia's Max: The unencrypted super-app being forced on citizens
-
EU chief in Australia with eyes on trade deal
-
Asia champions Japan need 'different tools' to win World Cup - coach
-
Global economy under 'major threat' from Strait of Hormuz crisis: IEA chief
-
Planet trapped record heat in 2025: UN
-
Israel launches new strikes on Tehran as Iran takes aim at Gulf sites
-
German court to rule in climate case against automakers
-
France's leftists win mayoral elections in largest cities
-
Asian stocks tumble as Trump gives Iran 48-hour ultimatum
-
Wolves rally past Celtics, Nuggets sink Blazers
-
Middle East war to dominate Houston's 'Davos of Energy'
-
Kim holds off Korda charge to win LPGA Founders Cup
-
Trump orders immigration agents to airports amid crippling budget standoff
-
Providence Bank Named One of the Nation's Top 100 Community Banks
-
Black Book Research Releases New 2026 Payer IT Series Report on the Medicaid-to-Medicare Transition Tech Stack
-
Owens Financial Group Launches retireregal.com, a National Digital Platform for Retirement Planning
-
LINGA Introduces LINGA Mobile, Expanding Flexible POS Options for Modern Restaurant Service
-
Ai4 2026 Agenda Now Live, Featuring the World's Most Influential Leaders in Applied Artificial Intelligence
-
Anew Climate Joins Carbon Measures to Advance Global Carbon Accounting Standards and Policies Supporting Market-Based Solutions
-
BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
-
Crexendo Redefines Large-Scale Event Communications for the 2026 NABC Convention
-
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
-
Bell Rose Capital Launches Revolutionary UniteThe99 Social Media Platform on iOS and Android
-
MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies
-
DISRPT Agency, a Division of Dolphin Subsidiary The Door Powers "Art of Glam" During Oscars Week, Driving Cultural Momentum Into Camille Rose's Upcoming Beauté Noir
-
Trustmi Expands AI-Driven Platform to Stop Payment Fraud Before Money Moves
-
OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level
Med-X to Showcase Nature-Cide at AMCA's 92nd Annual Meeting
Nature-Cide to Highlight its Botanical Pest Control Solutions at Leading Mosquito Control Industry Event in Portland, Oregon
LOS ANGELES, CA / ACCESS Newswire / March 23, 2026 / Med-X, Inc. ("Med-X" or the "Company") (Nasdaq:MXRX), a leading innovator in all-natural pest control solutions, today announced that its flagship Nature-Cide® product line will be featured at the American Mosquito Control Association's (AMCA) 92nd Annual Meeting, taking place March 23-27, 2026, at the Oregon Convention Center in Portland, Oregon. Attendees are invited to visit Nature-Cide at Booth 214 to explore the Company's full portfolio of botanical pest management solutions.
The AMCA Annual Meeting is the premier educational and networking event for researchers, vector control professionals, public health officials, and industry leaders focused on mosquito control. The conference attracts hundreds of attendees annually and features scientific presentations, technical sessions, and an expansive exhibit hall showcasing the latest innovations in vector and pest management.
Nature-Cide's participation underscores Med-X's ongoing commitment to advancing safer, environmentally responsible alternatives within the professional vector control market. Nature-Cide products are formulated with a proprietary blend of botanical essential oils-including clove, cottonseed, cedar, and cinnamon-and have demonstrated effectiveness in independent third-party studies against a broad spectrum of insect. In addition to insect control, Nature-Cide products are also designed to repel rodents, reptiles, and certain bird species, without the harmful effects associated with traditional synthetic chemical pesticides.
Matthew Mills, CEO of Med-X, Inc. stated: "Our latest formulation, Nature-Cide Pest Management X2 Plus, which is OMRI listed, is proving very effective within the pest control industry. AMCA offers us the opportunity to continue making a difference in every aspect of pest control.
"Our management team, Board of Directors, as well as our shareholders are committed to continuing forging a path around the world to bring environmentally friendly solutions where they are needed the most."
About Med-X, Inc.
Med-X, Inc. (Nasdaq:MXRX) is a leading innovator of biological pest control solutions serving both consumer and professional markets worldwide. Nature-Cide®, the Company's flagship product line, provides a safer, all-natural alternative to conventional chemical pesticides and is formulated to kill or repel a wide range of pests. Med-X's comprehensive go-to-market strategy includes strategic partnerships, as well as an integrated presence across e-commerce, retail, and on-site services in key markets. For more information, please visit www.medx-rx.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. These statements include, but are not limited to, statements regarding plans, objectives, strategies, future events, and expected performance. Words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," and similar expressions are intended to identify forward-looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including factors such as market conditions, competitive dynamics, regulatory developments, and other risks detailed in the Company's filings with the U.S. Securities and Exchange Commission (SEC). Investors are cautioned not to place undue reliance on forward-looking statements. Additional information can be found in the Company's SEC filings at www.sec.gov.
Investor Relations Contact
Lucas A. Zimmerman & Ian Scargill
MZ Group - MZ North America
(949) 259-4987
[email protected]
www.mzgroup.us
SOURCE: Med-X, Inc.
View the original press release on ACCESS Newswire
P.M.Smith--AMWN